Cochlear Limited announced that Non-executive Director Andrew Denver has advised his intention to retire from the Cochlear Board at the end of the next annual general meeting which will be held on 17 October 2023. Mr. Andrew Denver joined the Cochlear Board on 1 February 2007 and has served as a member of the Audit and Risk, Medical Science, Nomination and Product & Services Innovation Committees.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
322.6 AUD | +0.83% | +0.47% | +8.00% |
29/05 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
21/05 | Cochlear Completes Acquisition of Oticon Medical's Cochlear Implant Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 14.03B | |
-13.72% | 20.65B | |
+11.15% | 10.41B | |
-20.38% | 1.99B | |
+3.10% | 1.76B | |
+8.31% | 1.33B | |
+6.05% | 552M | |
-.--% | 421M | |
+69.47% | 196M | |
+11.28% | 88.9M |
- Stock Market
- Equities
- COH Stock
- News Cochlear Limited
- Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023